Skip to main content
. 2018 Jun 8;12:1645–1657. doi: 10.2147/DDDT.S167077

Figure 4.

Figure 4

Forest plots of incidences of high-grade hematologic toxicities during PD-1 inhibitor combination therapy: (A) anemia, (B) thrombocytopenia, (C) leukopenia, and (D) neutropenia.

Abbreviations: PD-1, programmed cell death-1; IV, inverse variance.